Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
India · Delayed Price · Currency is INR 365.35
+5.55 (1.54%)
Jul 31, 2026, 3:29 PM IST
NSE:INDRAMEDCO Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 14,825 | 14,825 | 13,564 | 12,447 | 10,987 | 8,882 |
Revenue Growth | 9.30% | 9.30% | 8.97% | 13.29% | 23.70% | 44.80% |
Gross Profit Gross Profit Growth | 5,492 | 5,492 | 8,286 | 7,407 | 6,357 | 4,823 |
Operating Income Operating Income Growth | 2,233 | 2,233 | 2,005 | 1,545 | 1,123 | 851.3 |
Net Income Net Income Growth | 1,836 | 1,836 | 1,610 | 1,240 | 861.5 | 586.2 |
Earnings Per Share EPS Growth | 20.03 | 20.03 | 17.56 | 13.52 | 9.40 | 6.39 |
EPS Growth | 14.07% | 14.07% | 29.88% | 43.87% | 47.07% | 2456.00% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,633 | 2,633 | 3,186 | 2,219 | 1,262 | 660.1 |
Total Debt Total Debt Growth | 368.6 | 368.6 | 327.6 | 339.5 | 24.8 | 53.1 |
Net Cash (Debt) Net Cash Growth | 2,264 | 2,264 | 2,858 | 1,879 | 1,237 | 607 |
Net Cash Growth | -20.78% | -20.78% | 52.12% | 51.86% | 103.84% | 254.76% |
Net Cash Per Share Net Cash Per Share Growth | 24.70 | 24.70 | 31.18 | 20.50 | 13.50 | 6.62 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,674 | 1,674 | 1,568 | 2,002 | 1,445 | 943 |
Capital Expenditures CapEx Growth | -596.5 | -596.5 | -363.3 | -693.9 | -445.8 | -294.8 |
Free Cash Flow Free Cash Flow Growth | 1,078 | 1,078 | 1,204 | 1,308 | 998.9 | 648.2 |
Free Cash Flow Growth | -10.49% | -10.49% | -7.91% | 30.90% | 54.10% | 1008.03% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 37.04% | 37.04% | 61.09% | 59.51% | 57.86% | 54.30% |
Operating Margin | 15.06% | 15.06% | 14.78% | 12.41% | 10.22% | 9.59% |
Pretax Margin | 16.59% | 16.59% | 15.95% | 13.35% | 10.67% | 8.90% |
Profit Margin | 12.39% | 12.39% | 11.87% | 9.96% | 7.84% | 6.60% |
FCF Margin | 7.27% | 7.27% | 8.88% | 10.51% | 9.09% | 7.30% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 4.000 | 4.000 | 4.500 | 4.500 | 3.000 | 2.500 |
Dividend Per Share Growth | 0% | -11.11% | 0% | 50.00% | 20.00% | - |
Dividend Yield | 1.09% | 1.07% | 1.18% | 2.68% | 4.04% | 4.60% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 18.29 | 18.59 | 21.99 | 12.67 | 8.20 | 9.13 |
P/FCF Ratio | 31.16 | 31.67 | 29.39 | 12.01 | 7.07 | 8.26 |
PS Ratio | 2.27 | 2.30 | 2.61 | 1.26 | 0.64 | 0.60 |